Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
471,674
-
Shares change
-
+122,210
-
Total reported value, excl. options
-
$304,570
-
Value change
-
+$67,746
-
Number of buys
-
9
-
Number of sells
-
-6
-
Price
-
$0.6472
Significant Holders of IMPACT BIOMEDICAL INC. - COMMON STOCK (IBO) as of Q2 2025
21 filings reported holding IBO - IMPACT BIOMEDICAL INC. - COMMON STOCK as of Q2 2025.
IMPACT BIOMEDICAL INC. - COMMON STOCK (IBO) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 471,674 shares
.
Largest 10 shareholders include BlackRock, Inc. (252,730 shares), GEODE CAPITAL MANAGEMENT, LLC (49,869 shares), UBS Group AG (39,725 shares), VANGUARD GROUP INC (32,437 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (30,824 shares), TWO SIGMA INVESTMENTS, LP (22,700 shares), STATE STREET CORP (11,797 shares), StoneX Group Inc. (10,794 shares), HRT FINANCIAL LP (10,326 shares), and CITIGROUP INC (8,784 shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.